CatalystPit

SRRKScholar Rock Holding Corp

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $48.32 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$5.88B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-25 · Woods Keith (Chief Operating Officer) · OTHER
  • 2026-09-23 · Hallal David (Chief Executive Officer) · OTHER
  • 2026-07-06 · Burow Kristina (Director) · SELL
  • 2026-07-06 · FLIER JEFFREY S. (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders328
Shares held153,420,480
Value$7.66B
Percent of shares outstanding125.98%
As of quarter end2026-06-30
RECENT NEWS
  • SRRK: Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm
  • Scholar Rock added to Wedbush's Best Ideas List
  • JPMorgan raises Scholar Rock stock price target to $70 on launch outlook
  • Scholar Rock: Reiterating 'Strong Buy' On FDA Approval SMA And Expansions Now In Play
  • Barclays downgrades Scholar Rock following FDA approval of SMA therapy
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Scholar Rock Holding Corp (SRRK) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit